Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Abstract
Autologous hematopoietic stem cell transplant (AHSCT) for multiple sclerosis has gained increasing interest in recent years. Despite the availability of many US Food and Drug Administration-approved disease-modifying therapies, some patients do not respond adequately and others may have very early aggressive disease that prompts consideration of alternative, highly effective, long-lasting therapy. The National Medical Advisory Committee of the...
Paper Details
Title
Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis
Published Date
Feb 1, 2021
Journal
Volume
78
Issue
2
Pages
241 - 241
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History